Acima Private Wealth’s Labcorp LH Stock Holding History

Acima Private Wealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14	Closed	-$2K	–	280
2019 Q4	$2K	Hold	14	–	–	﹤0.01%	282
2019 Q3	$2K	Hold	14	–	–	﹤0.01%	255
2019 Q2	$2K	Hold	14	–	–	﹤0.01%	238
2019 Q1	$2K	Hold	14	–	–	﹤0.01%	238
2018 Q4	$2K	Buy	+14	New	+$1.88K	﹤0.01%	251

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acima Private Wealth's LH Position: Q1 2020 in Review

Acima Private Wealth sold out of Labcorp (LH) in Q1 2020, closing a stake of 14 shares — an estimated $2K sold.

Acima Private Wealth first reported a position in LH in Q4 2018 and held it in 5 quarters. The position peaked at $2K in Q4 2019. 760 funds tracked by Wall St. Rank hold LH as of Q1 2020.

Acima Private Wealth reported no remaining Labcorp position as of Q1 2020 after selling out during the quarter.
Acima Private Wealth sold 14 Labcorp shares in Q1 2020, an estimated $2K.
Acima Private Wealth first reported a position in Labcorp in Q4 2018 and held it in 5 quarters.
Acima Private Wealth's Labcorp position peaked at $2K in Q4 2019.
760 funds tracked by Wall St. Rank held Labcorp as of Q1 2020.

Based on Acima Private Wealth's 13F filing for Q1 2020, filed 1 May 2020.